GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Biomimetic Therapeutics, Inc. (BMTI) [hlAlert]

Rating:
Buy BMTI
down 24.56 %

Biomimetic Therapeutics, Inc. (BMTI) rated Buy

Posted on: Thursday,  Dec 6, 2007  9:25 AM ET by Boenning & Scattergood

Boenning & Scattergood rated Buy Biomimetic Therapeutics, Inc. (NASDAQ: BMTI) on 12/06/2007, when the stock price was $12.58.
Since then, Biomimetic Therapeutics, Inc. has lost 24.56% as of 02/28/2013's recent price of $9.49.
If you would have followed this Boenning & Scattergood's recommendation on BMTI, you would have lost 24.56% of your investment in 1911 days.

BioMimetic Therapeutics, Inc. (BioMimetic) develops and commercializes products to stimulate the body?s natural tissue regenerative process. The Company?s protein therapeutic-device combination products are used for the treatment of musculoskeletal injuries and conditions affecting bones, tendons, ligaments, and cartilage. The Company?s platform regenerative technology, which incorporates a potent version of one of the body?s natural key stimulators of tissue repair, may offer physicians advanced biological solutions to actively stimulate tissue healing and regeneration. The Company focuses on developing GEM 21S technology to stimulate tissue healing in orthopedic applications (such as distal radius, or wrist, fractures and fusions of the bones in the foot and ankle to eliminate chronic pain from trauma or arthritis), and potentially spine and sports injury applications.

Our equity research team concentrates on companies that aren’t widely covered in sectors such as water distribution/equipment/technology, financial services, business services, aerospace & defense technology, medical technology and retail.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/17/2007 8:25 AM Buy
None
15.41 20.00
as of 8/27/2015
1 Week   
1 Month   
3 Months   
1 YTD down  -17.04 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/6/2007 9:25 AM Buy
None
12.58 18.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy